Last reviewed · How we verify
NCT01778517
Treatment of Functional Movement Disorders With Psychotherapy
NA trial testing Group Psychotherapy in Movement Disorders in 9 participants. Completed in 23 July 2015.
23 July 2015
Quick facts
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS) |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 9 |
| Start date | 11 December 2012 |
| Primary completion | 23 July 2015 |
| Estimated completion | 23 July 2015 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Group Psychotherapy
- Cognitive behavior therapy based on self help
Conditions studied
- Movement Disorders — all drugs for Movement Disorders →
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Who can join
Adults 18 to 85, any sex, with Movement Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: \- Functional movement disorder (FMD) is a form of conversion disorder (CD). CD is a disorder in which a person has neurological symptoms that do not have a neurological cause. These symptoms can include pain, weakness, dizziness, and fatigue. Some thoughts on CD suggest that it may come from feelings of anxiety that are converted into physical symptoms. Treatment for FMD usually involves stress reduction, family help, and regular doctor s appointments. Therapy interventions, however, have not been well studied. Researchers want to see if people with FMD get better with psychotherapy. They will study two different types of psychotherapy: group therapy and a self-help manual. Objectives: \- To test two different types of therapy treatments for FMD. Eligibility: \- Individuals at least 18 years of age who have been diagnosed with FMD by a neurologist. Design: * Participants will be screened with a physical exam and medical history. They will also have a psychological exam, and answer questions about their mood and symptoms. * Participants will be separated into three groups. One group will have group therapy. Another will use a self-help workbook designed for people with FMD, and have individual therapy sessions. A third group will just have standard care. During the study, participants will continue to see their regular doctor. * Group therapy participants will meet once a week for 6 months at the National Institutes of Health clinical center. There will be 8 to 10 people per group. Sessions will last 75 minutes. These sessions will work on methods for treating FMD. * Self-help workbook participants will have six individual therapy sessions over 3 to 4 months. They will use the workbooks to learn about and practice methods for treating FMD. * All participants will be evaluated at 3, 6, and 12 months during the study. * At the end of the study, participants will have a final follow-up session with exams and questions similar to the screening exam. They will return to the care of their regular doctor.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Psychosocial interventions for conversion and dissociative disorders in adults.
Ganslev CA, Storebø OJ, Callesen HE, Ruddy R, et al · · 2020 · cited 14× · PMID 32681745 · DOI 10.1002/14651858.cd005331.pub3
Verify or expand the search:
- PubMed search for NCT01778517
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Group Psychotherapy
Trials testing the same drug.
- NCT06726772 — Group Psychotherapy in Long COVID · NA · completed
- NCT04517929 — Effectiveness of Group Psychotherapy in Patients With Fibromyalgia Syndrome · NA · completed
Other recruiting trials for Movement Disorders
Currently open trials in the same condition.
- NCT07384442 — Effects of Targeted Temporal Interference Stimulation of Cerebellar Nuclei on Tremor and Gait Disturbance in Parkinson's · NA · recruiting
- NCT05926596 — Leg Stretching Using an Exoskeleton on Demand for People With Spasticity · NA · recruiting
- NCT07236892 — Towards Restoring Complex Movement After Paralysis: Algorithm Development With Healthy Participants · NA · recruiting
- NCT06821230 — Dyadic Mindfulness for People With Parkinson's Disease and Their Caregivers · NA · recruiting
- NCT06088355 — Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease · NA · recruiting
Other National Institute of Neurological Disorders and Stroke (NINDS) trials
Trials by the same sponsor.
- NCT07137442 — Distinguishing Tics and Functional Tics Using Clinical Neurophysiological Techniques · recruiting
- NCT02522611 — Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain · Phase 1, PHASE2 · not yet recruiting
- NCT07511049 — Intravenous Brincidofovir as an Antiviral for Treatment of Progressive Multifocal Leukoencephalopathy: A Pilot Study · Phase 2 · not yet recruiting
- NCT07416188 — Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma · Phase 1, PHASE2 · not yet recruiting
- NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01778517 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Institute of Neurological Disorders and Stroke (NINDS)
- Last refreshed: 2 July 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01778517.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing